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The interaction between the Ca2+-activated neutral protease (CANP) and its endogenous inhibitor was ana- 
lyzed. The interaction was completely reversible, and both CANP and the inhibitor regained full activity 
after dissociation of their complex. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The Ca2+-activated neutral protease (CANP) is 
involved in a variety of physiological processes in 
vertebrate cells [l-4]. The activity of CANP, as an 
intracellular protease, is strictly regulated by 
various mechanisms. Among them, the concentra- 
tion of Ca2+ in the cell is the most important fac- 
tor. An endogenous proteinaceous inhibitor in- 
hibits CANP non-competitively through the for- 
mation of a complex in the presence of Ca2+ [5-71. 
Melloni et al. [8] reported that CANP and the in- 
hibitor dissociate into 80 kDa and 30 kDa 
subunits, and 60 kDa subunit, respectively, in the 
presence of Ca2+, and that the 60 kDa subunit of 
the inhibitor binds to the 80 kDa subunit of CANP 
to form a 140 kDa complex. However, little is 
known about the interaction of CANP with the in- 
hibitor, namely, whether the interaction is reversi- 
ble or not. 
2.1. Preparation of CANP and its inhibitor 
CANP inhibitor was prepared from human liver 
as described in 191. The specific activity was 2500 
units/mg. Chicken CANP was prepared from 
skeletal muscle according to Ishiura et al. [lo]. 
Carboxymethylated-CANP (Cm-CANP) was pre- 
pared from purified chicken CANP (spec. act. 490 
units/mg) as described in [l l] with 
iodo[2-3H]acetic acid (Radiochemical Centre). 
Cm-CANP showed no proteolytic activity (spec. 
act. co.3 units/mg), and the incorporation of car- 
boxymethyl groups was determined from the in- 
corporated radioactivity to be 1.2 mol/mol 
CANP. 
2.2. Formation and dissociation of the 
CANP-inhibitor complex 
The following conditions were used except when 
Recently, we purified the inhibitor (Mr = 
107000) from human liver, and demonstrated that 
1 mol inhibitor inhibits 5 mol CANP from various 
sources [9]. Here, we analyzed the reaction be- 
tween chicken CANP and CANP inhibitor from 
human liver, and revealed that the interaction is 
completely reversible. 
otherwise indicated. CANP and the inhibitor were 
incubated in 50 mM Tris-HCl, pH 7.6, 1 mM 
CaCl2, 5 mM 2-mercaptoethanol (buffer A) for 
20 min at 30°C for formation of the complex. 
Dissociation of the complex was performed by ad- 
dition of EDTA (final concentration: 5 mM) to the 
complex solution followed by incubation of the 
mixture for 10 min at 30°C. 
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2.3. Separation of CANP from the inhibitor on 
pheny~-~epharose CL-4B 
To 50 ~1 of a mixture of CANP and the inhibitor 
in the absence of Ca’+, concentrated NaCI solution 
was added to a final concentration of 0.4 M, and 
then 50 ~1 phenyl-Sepharose CL-4B (Pharmacia) 
swollen in 0.4 M NaCl was added. The mixture 
was vortex-mixed and centrifuged for 15 s at 
10000 x g. CANP was adsorbed by the phenyl- 
Sepharose CL-4B under these conditions, and the 
supernatant contained only the inhibitor. 
2.4. Other methods 
The activities of CANP and the inhibitor were 
measured with casein as a substrate as described in 
[9,10]. One unit of the inhibitor activity was de- 
fined as the amount of the inhibitor which com- 
pletely inactivated one unit of CANP. SDS-poly- 
acrylamide gel electrophoresis (7.5% gel) was car- 
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Fig.1. Analysis of interaction between CANP and its 
inhibitor by SDS-polyacrylamide gel eIectrophoresis. 
The inhibitor (2.4 pmol) was incubated in buffer A with 
various amounts of CANP: (1) none, (2) 6 pmol, (3) 
12 pmol, (4) 24 pmol, to form the CANP-inhibitor 
complex. The complex was dissociated with EDTA and 
subjected to SDS-polyacrylamide gel electrophoresis. 
CANP (20 pmol) without incubation with Ca*+ is in lane 
5. Triplet bands seen below the CANP band were 
Fig.2. Interaction of Cm-CANP with the inhibitor. 
Various amounts of Cm-CANP (O-120 pmol) were 
incubated with 12 pmol inhibitor in buffer A. After 
incubation (o), native CANP (60 pmol) was added to 
the mixture and the caseinolytic activity of the added 
CANP was measured. The results obtained when Cm- 
CANP and native CANP were added together are also 
shown (0). The activity was expressed as the % of that 
measured without the inhibitor. Thick lines indicate 
theoretical curves when Cm-CANP is added previously 
(A) and together (B) with native CANP, assuming that 
Cm-CANP is fully active in the interaction with the 
impurities in the CANP preparation used. inhibitor. 
ried out according to the method of Laemmli [12], 
and the gel was stained with Coomassie blue. 
3. RESULTS 
3.1. Electrophoretic analysis of rhe interaction 
between CANP and the inhibitor 
A fixed amount of the inhibitor was incubated 
with various amounts of CANP in the presence of 
I mM Ca2+, and each incubated sample was sub- 
jected to SDS-polyacrylamide gel electrophoresis 
(fig.1). When an excess amount of the inhibitor 
was present (lane 2), neither CANP nor the in- 
hibitor was degraded, as judged by elec- 
trophoresis, because CANP was inactivated on the 
formation of a complex with the inhibitor. 
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However, the inhibitor was degraded to small 
fragments when the amount of CANP exceeded 
that of the inhibitor, and the native inhibitor could 
hardly be seen (lane 4). 
3.2. rn~eru~i~o~ between Cm-CANP and the 
inhibitor 
Reaction of Cm-CANP with the inhibitor was 
examined on the basis of the competitive interac- 
tion of Cm-CANP and native CANP with the in- 
hibitor. The inhibitor preincubated with Cm- 
CANP was almost completely inactive with respect 
to inhibition of native CANP added afterwards 
(fig.2). However, when Cm-CANP and native 
CANP were added together, the activity of the in- 
hibitor for native CANP was suppressed to 
30-40% in the presence of a 2-fold molar excess of 
Cm-CANP over native CANP. These results in- 
dicate that the interaction of Cm-CANP with the 
inhibitor was similar to that for native CANP. 
4 8 12 16 
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Fig.3. Reversible interaction of CANP with the 
inhibitor. Various amounts of the inhibitor were 
incubated with 54 pmol CANP in buffer A containing 
3 mglml casein at 0°C for 10 min. After incubation, 
EDTA was added, and the sample was incubated at 0°C 
for a further I5 min. To the incubated sample, 120 pmot 
Cm-CANP was added, and the CANP activity was 
measured (=) on addition of Ca*+ again to a final 
concentration of 5 mM. As a control, the above 
procedure was carried out without incubation with 
EDTA ( q ), and without the addition of Cm-CANP (A). 
Table I 
Recovery of the inhibitor after interaction with CANPa 
Sample Conditions Inhibitor 
activity of the 
supernatant 
(@Jo) 
Inhibitor plus 
CANP 104 
centrifuged 
without NaClb 3 
incubated without 
CaCl2 100C 
Inhibitor without 
CANP - 78 
incubated 
without CaCl2 108 
a CANP (200 pmol) was incubated with 200 pmol 
inhibitor in buffer A and the complex formed was 
dissociated in EDTA. Then, CANP was removed by 
the phenyl-Sepharose CL4B method, and the inhibitor 
activity of the supernatant was measured 
b See section 2.3 
’ Value taken as 100% 
3.3, Activity of CANP recovered from the 
CANT-inhibitor complex 
CANP was incubated with various amounts of 
the inhibitor in buffer A. The CANP-inhibitor 
complex was dissociated by the addition of EDTA 
and the recovery of the CANP activity was ex- 
amined in the presence of a 2-fold molar excess of 
Cm-CANP which was added to prevent reforma- 
tion of the native CANP-inhibitor complex (fig.3). 
The recovery was about 70%, indicating that 
CANP was fully active after dissociation from the 
CANP-inhibitor complex based on the results 
described above. 
3.4. Recovery of inhibitor activity from the 
CANP-inhibitor complex 
The CANP-inhibitor complex was dissociated in 
EDTA, and the inhibitor activity was examined 
after removal of CANP with phenyl-Sepharose 
CL-4B. As shown in table 1, all the inhibitor activi- 
ty was recovered in the supernatant fraction after 
dissociation from the inhibitor-CANP complex. 
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4. DISCUSSION ACKNOWLEDGEMENTS 
CANP inhibitor has been purified from various 
animal tissues [13]. However, there have been few 
reports describing the mode of interaction between 
CANP and the inhibitor. Cottin et al. [5,6] in- 
vestigated the interaction by using CANP and the 
inhibitor immobilized in agarose. Melloni et al. 
[8,14] isolated the CANP-inhibitor complex by gel 
filtration in the presence of Ca’+, and observed 
that the interaction is Ca’+-dependent. These 
methods, however, are not suitable for analyzing 
quantitatively the interaction of CANP with the in- 
hibitor on a molar basis. As shown in fig. 1, excess 
CANP digests the inhibitor. Therefore, stoichio- 
metric analysis of the interaction is necessary. In 
the present study the interaction between CANP 
and the inhibitor was analyzed quantitatively in 
vitro. Both CANP and the inhibitor regained full 
activity after dissociation of their complex. Fur- 
thermore, no changes were observed in their elec- 
trophoretic mobilities after formation of the com- 
plex. These results indicate that the in vivo activity 
of CANP is reversibly regulated by the inhibitor, 
and that the interaction is regulated solely by Ca2+. 
Thus, the intracellular balance of their amounts is 
a very important factor for the regulation of 
CANP activity. Several investigators stated that 
CANP inhibitor is an oligomeric protein, judging 
from its elution position on gel filtration 
[8,14-161. Melloni et al. [B] reported that the in- 
hibitor is dissociated into subunits in the presence 
of Ca’+. The inhibitor preparation used here is 
monomeric and we did not observe any change in 
the molecular mass as estimated by gel filtration 
after dissociation from the complex (not shown). 
This study was supported in part by research 
grants from the Ministry of Education, Science 
and Culture, a grant-in-aid for new drug develop- 
ment from the Ministry of Health and Welfare of 
Japan. 
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